These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 18980980)
1. Sulforaphane enhances the therapeutic potential of TRAIL in prostate cancer orthotopic model through regulation of apoptosis, metastasis, and angiogenesis. Shankar S; Ganapathy S; Srivastava RK Clin Cancer Res; 2008 Nov; 14(21):6855-66. PubMed ID: 18980980 [TBL] [Abstract][Full Text] [Related]
2. Diallyl trisulfide increases the effectiveness of TRAIL and inhibits prostate cancer growth in an orthotopic model: molecular mechanisms. Shankar S; Chen Q; Ganapathy S; Singh KP; Srivastava RK Mol Cancer Ther; 2008 Aug; 7(8):2328-38. PubMed ID: 18723480 [TBL] [Abstract][Full Text] [Related]
3. Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-resistant hepatoma cells to TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of DR5. Kim H; Kim EH; Eom YW; Kim WH; Kwon TK; Lee SJ; Choi KS Cancer Res; 2006 Feb; 66(3):1740-50. PubMed ID: 16452234 [TBL] [Abstract][Full Text] [Related]
4. Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice. Shankar S; Davis R; Singh KP; Kurzrock R; Ross DD; Srivastava RK Mol Cancer Ther; 2009 Jun; 8(6):1596-605. PubMed ID: 19509267 [TBL] [Abstract][Full Text] [Related]
5. Effects of sequential treatments with chemotherapeutic drugs followed by TRAIL on prostate cancer in vitro and in vivo. Shankar S; Chen X; Srivastava RK Prostate; 2005 Feb; 62(2):165-86. PubMed ID: 15389801 [TBL] [Abstract][Full Text] [Related]
7. Ionizing radiation enhances the therapeutic potential of TRAIL in prostate cancer in vitro and in vivo: Intracellular mechanisms. Shankar S; Singh TR; Srivastava RK Prostate; 2004 Sep; 61(1):35-49. PubMed ID: 15287092 [TBL] [Abstract][Full Text] [Related]
8. MS-275 sensitizes TRAIL-resistant breast cancer cells, inhibits angiogenesis and metastasis, and reverses epithelial-mesenchymal transition in vivo. Srivastava RK; Kurzrock R; Shankar S Mol Cancer Ther; 2010 Dec; 9(12):3254-66. PubMed ID: 21041383 [TBL] [Abstract][Full Text] [Related]
9. Resveratrol enhances antitumor activity of TRAIL in prostate cancer xenografts through activation of FOXO transcription factor. Ganapathy S; Chen Q; Singh KP; Shankar S; Srivastava RK PLoS One; 2010 Dec; 5(12):e15627. PubMed ID: 21209944 [TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells. Shankar S; Siddiqui I; Srivastava RK Mol Cell Biochem; 2007 Oct; 304(1-2):273-85. PubMed ID: 17636462 [TBL] [Abstract][Full Text] [Related]
11. Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11. Ray S; Almasan A Cancer Res; 2003 Aug; 63(15):4713-23. PubMed ID: 12907654 [TBL] [Abstract][Full Text] [Related]
12. Phenethyl isothiocyanate enhances TRAIL-induced apoptosis in oral cancer cells and xenografts. Yeh CC; Ko HH; Hsieh YP; Wu KJ; Kuo MY; Deng YT Clin Oral Investig; 2016 Dec; 20(9):2343-2352. PubMed ID: 26822174 [TBL] [Abstract][Full Text] [Related]
13. Acetylshikonin Sensitizes Hepatocellular Carcinoma Cells to Apoptosis through ROS-Mediated Caspase Activation. Hong M; Li J; Li S; M Almutairi M Cells; 2019 Nov; 8(11):. PubMed ID: 31752383 [TBL] [Abstract][Full Text] [Related]
14. Upregulation of Death Receptor 5 and Production of Reactive Oxygen Species Mediate Sensitization of PC-3 Prostate Cancer Cells to TRAIL Induced Apoptosis by Vitisin A. Shin D; Kwon HY; Sohn EJ; Nam MS; Kim JH; Lee JC; Ryu SY; Park B; Kim SH Cell Physiol Biochem; 2015; 36(3):1151-62. PubMed ID: 26111475 [TBL] [Abstract][Full Text] [Related]
15. Inorganic selenium sensitizes prostate cancer cells to TRAIL-induced apoptosis through superoxide/p53/Bax-mediated activation of mitochondrial pathway. Hu H; Jiang C; Schuster T; Li GX; Daniel PT; Lü J Mol Cancer Ther; 2006 Jul; 5(7):1873-82. PubMed ID: 16891474 [TBL] [Abstract][Full Text] [Related]
16. TRAIL attenuates sulforaphane-mediated Nrf2 and sustains ROS generation, leading to apoptosis of TRAIL-resistant human bladder cancer cells. Jin CY; Molagoda IMN; Karunarathne WAHM; Kang SH; Park C; Kim GY; Choi YH Toxicol Appl Pharmacol; 2018 Aug; 352():132-141. PubMed ID: 29792947 [TBL] [Abstract][Full Text] [Related]
17. Bax and Bak are required for apoptosis induction by sulforaphane, a cruciferous vegetable-derived cancer chemopreventive agent. Choi S; Singh SV Cancer Res; 2005 Mar; 65(5):2035-43. PubMed ID: 15753404 [TBL] [Abstract][Full Text] [Related]
19. TRAIL and doxorubicin combination induces proapoptotic and antiangiogenic effects in soft tissue sarcoma in vivo. Wang S; Ren W; Liu J; Lahat G; Torres K; Lopez G; Lazar AJ; Hayes-Jordan A; Liu K; Bankson J; Hazle JD; Lev D Clin Cancer Res; 2010 May; 16(9):2591-604. PubMed ID: 20406839 [TBL] [Abstract][Full Text] [Related]
20. Sulforaphane generates reactive oxygen species leading to mitochondrial perturbation for apoptosis in human leukemia U937 cells. Choi WY; Choi BT; Lee WH; Choi YH Biomed Pharmacother; 2008 Nov; 62(9):637-44. PubMed ID: 18313257 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]